The Global Healthy Living Foundation assesses the importance of the FDA's proposed biosimilars naming guidelines.
Safety and Error Prevention
Low levels of adiponectin before pregnancy were associated with a 5-fold increased risk of gestational diabetes. This risk was 7-fold in obese or overweight women.
The current treatment of mild gestational diabetes mellitus results in fewer cases of preeclampsia, shoulder dystocia, and macrosomia but seems to have no effect on neonatal hypoglycemia or future poor metabolic outcomes, concluded a systematic review and meta-analysis.